[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES400624A1 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ES400624A1
ES400624A1 ES400624A ES400624A ES400624A1 ES 400624 A1 ES400624 A1 ES 400624A1 ES 400624 A ES400624 A ES 400624A ES 400624 A ES400624 A ES 400624A ES 400624 A1 ES400624 A1 ES 400624A1
Authority
ES
Spain
Prior art keywords
general formula
compound
pharmaceutical compositions
same meaning
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES400624A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES400624A1 publication Critical patent/ES400624A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Procedure for the preparation of derivatives of penicilloic acid, of the general formula ** (See formula) ** in which n represents 1, 2, 3, 4 or 5 and R represents the phenyl or 1,4-cyclohexa-dienyl group, and its salts, characterized by reacting a compound of the general formula ** (See formula) ** in which R has the same meaning as before, with a compound of the general formula H2N- (CH2) n-COOH (III) in which n has the same meaning as before, and, if desired, because the reaction product becomes a salt. (Machine-translation by Google Translate, not legally binding)
ES400624A 1971-03-11 1972-03-10 Pharmaceutical compositions Expired ES400624A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH355871 1971-03-11

Publications (1)

Publication Number Publication Date
ES400624A1 true ES400624A1 (en) 1975-02-01

Family

ID=4258572

Family Applications (2)

Application Number Title Priority Date Filing Date
ES400623A Expired ES400623A1 (en) 1971-03-11 1972-03-10 Pharmaceutical compositions
ES400624A Expired ES400624A1 (en) 1971-03-11 1972-03-10 Pharmaceutical compositions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES400623A Expired ES400623A1 (en) 1971-03-11 1972-03-10 Pharmaceutical compositions

Country Status (21)

Country Link
AT (2) AT312802B (en)
AU (1) AU461136B2 (en)
BE (2) BE780472A (en)
CA (1) CA972759A (en)
CH (1) CH546783A (en)
DE (2) DE2211420A1 (en)
DK (1) DK136977B (en)
ES (2) ES400623A1 (en)
FI (1) FI52345C (en)
FR (2) FR2128823B1 (en)
GB (2) GB1333524A (en)
HK (1) HK14676A (en)
HU (2) HU166712B (en)
IE (2) IE36204B1 (en)
IL (2) IL38865A (en)
NL (2) NL7202771A (en)
NO (1) NO138142C (en)
PH (2) PH12264A (en)
SE (3) SE406198B (en)
YU (1) YU35011B (en)
ZA (2) ZA721363B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4316882A (en) * 1978-04-20 1982-02-23 Levine Bernard B Compositions for testing to predict and/or diagnose allergy to penicillins
CA1209477A (en) * 1981-03-26 1986-08-12 Bruce E. Haeger Composition of matter comprising a lyophilized preparation of a penicillin derivative

Also Published As

Publication number Publication date
IL38864A0 (en) 1972-05-30
GB1322149A (en) 1973-07-04
IL38865A0 (en) 1972-05-30
HU165203B (en) 1974-07-27
IE36203B1 (en) 1976-09-15
FR2128824B1 (en) 1975-06-13
SE7513807L (en) 1975-12-08
ZA721364B (en) 1972-11-29
NL7202772A (en) 1972-09-13
AU461136B2 (en) 1975-04-30
CH546783A (en) 1974-03-15
YU62572A (en) 1979-12-31
IE36203L (en) 1972-09-11
IE36204B1 (en) 1976-09-15
YU35011B (en) 1980-06-30
ATA188672A (en) 1975-11-15
IE36204L (en) 1972-09-11
NL7202771A (en) 1972-09-13
BE780471A (en) 1972-09-11
PH9295A (en) 1975-08-15
NO138142B (en) 1978-04-03
SE7514031L (en) 1975-12-11
AT331389B (en) 1976-08-25
CA972759A (en) 1975-08-12
PH12264A (en) 1978-12-12
SE406198B (en) 1979-01-29
FR2128823A1 (en) 1972-10-20
IL38865A (en) 1975-08-31
DE2211419A1 (en) 1972-09-21
FI52345B (en) 1977-05-02
FI52345C (en) 1977-08-10
IL38864A (en) 1975-08-31
BE780472A (en) 1972-09-11
FR2128823B1 (en) 1975-04-25
GB1333524A (en) 1973-10-10
AT312802B (en) 1974-01-25
DK136977C (en) 1978-06-05
ZA721363B (en) 1972-11-29
DE2211420A1 (en) 1972-09-21
AU3957172A (en) 1973-09-06
FR2128824A1 (en) 1972-10-20
HU166712B (en) 1975-05-28
HK14676A (en) 1976-03-26
ES400623A1 (en) 1975-02-01
DK136977B (en) 1977-12-27
NO138142C (en) 1978-07-12

Similar Documents

Publication Publication Date Title
ES327909A1 (en) Procedure for the obtaining of derivatives of 4-chlorine-5-sulfamilsalicilico acid. (Machine-translation by Google Translate, not legally binding)
SE7411243L (en)
ES391633A1 (en) 2,2,-diaryl-4-4-aryl-4-hydroxy-piperidino butyramides
ES400624A1 (en) Pharmaceutical compositions
ES368955A1 (en) Procedure for preparing substitute guanidines. (Machine-translation by Google Translate, not legally binding)
ES405456A1 (en) 7-Alkoxycarbonyl-4-hydroxymethyl-1-phthalazone compounds
NL7410826A (en) PROCESS FOR THE PREPARATION OF INDAZOLE-3-CARBONIC ACID HYDRAZIDES.
ES446701A1 (en) Biphenyl derivatives and pharmaceutical compositions thereof
ES401228A1 (en) Pharmaceutical composition containing a zinc-cysteine complex
ES444526A1 (en) Guanidine derivatives their preparation and antiviral compositions containing them
ES419439A1 (en) Carbamoyl sulphoxides
ES419386A1 (en) Indenopyrrole derivatives
ES412068A1 (en) Xylidides
ES403172A1 (en) 2,2-disubstituted omega-(1,4-diazabicyclo(4.4.0)-decane)alkanamides and related compounds
ES388822A1 (en) Biocidal composition and disinfecting method
ES398080A1 (en) 1-(1,2-diphenyl-2-formylvinyl)-4-methylpiperazine and salts thereof with physiologically tolerated acids
ES391036A1 (en) A procedure for the preparation of N-substituted derivatives of compounds of 14-hydroxydehydronormorfin. (Machine-translation by Google Translate, not legally binding)
ES398868A1 (en) Process for the preparation of derivatives of 1,2-diphenyl-3,5- dioxo-4-n-butylpyrazolidine
ES363742A1 (en) N-Substituted 2-Hydroxymorphinanes and Pharmaceutical Compositions containing them
ES308480A1 (en) Procedure for the preparation of new salts of the embonic acid. (Machine-translation by Google Translate, not legally binding)
ES405105A1 (en) A process for the preparation of 2,6,6-trimethyl-1- (1 0'-carboxy-3 ', 7'-dimethyl-deca-1', 3 ', 5', 7 ', 9' - pentaenil) -cicolhexi-eno or a salt of the same. (Machine-translation by Google Translate, not legally binding)
ES427954A1 (en) Preparation of n * n*n** tricyclohexylln * n*n**trimethyll triamidephosphate
ES409217A1 (en) F 5-nitroimidazole derivatives
GB1032268A (en) New guanyl-hydrazones and preparations containing them
ES402551A1 (en) A procedure for the preparation of piperazine derivatives. (Machine-translation by Google Translate, not legally binding)